Table 4.
Effects of zofenopril on ACE activity in plasma, aorta and heart
ACE activity [nmol HL·(mg protein)−1·min−1] | SHR | Z0.5 | Z10 | WKY |
---|---|---|---|---|
PLASMA | 2.44 ± 0.25# | 1.86 ± 0.12 | 0.41 ± 0.09* | 1.09 ± 0.23 |
AORTA | 5.05 ± 0.58# | 2.49 ± 0.35* | 1.45 ± 0.42* | 1.97 ± 0.64 |
HEART | 0.052 ± 0.01# | 0.022 ± 0.01* | 0.015 ± 0.00* | 0.012 ± 0.00 |
Values are means ± SEM.
P < 0.05 compared with SHR;
P < 0.05 compared with WKY.
SHR, spontaneously hypertensive rats; Z0.5, SHR treated with zofenopril 0.5 mg·kg−1 per day; Z10, SHR treated with zofenopril 10 mg·kg−1 per day; WKY, Wistar-Kyoto rats.